Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of sclerodermaFlavia V. Castelino, Andrew M. Tager, Gretchen Bain et al.|Arthritis & Rheumatism|2011Cited by 168